CDKN2A/p16INK4a monoclonal antibody
Product Specifications
Background
Acts as a negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6. This inhibits their ability to interact with cyclins D and to phosphorylate the retinoblastoma protein.CautionThe proteins described here are encoded by the gene CDKN2A, but are completely unrelated in terms of sequence and function to tumor suppressor ARF (AC Q64364) which is encoded by the same gene.
CAS Number
9007-83-4
Structure Composition
50mM Tris-Glycine (pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA
Product Name Alternative
Cdkn2a; P16ink4a; Cyclin-dependent kinase 4 inhibitor A (CDK4I) ; p16-INK4a ; p16-INK4
Swiss Prot
P51480
Reactivity
Mouse, Rat
Immunogen
Recombinant protein of mouse CDKN2A/p16INK4a
Conjugation
Unconjugated
Applications
WB, ICC/IF, IP
Dilution
WB: 1/500-1/1000 IF: 1/50-1/200 IP: 1/20
Purity
Affinity Purified
Modification
Unmodified
Molecular Weight
Calculated MW: 18 kDa; Observed MW: 18 kDa
Storage Conditions
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Notes
For research use only, not for use in diagnostic procedure.
Specificity
IgG
Applications Notes
Western blot analysis of CDKN2A/p16INK4a in 3T3 lysates using CDKN2A antibody.
Host or Source
Rabbit
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
T5595-5417 5 Sections
Tissue, Section, Human Tumor, Appendix Tumor, Adenocarcinoma (Paraffin) HisTekTM
Ask
View Details 
H8995-01 2.5 mg
Hydrochlorothiazide-13c1, d2 (6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-13c1, d2-7-sulfonamide 1,1-Dioxide)
Ask
View Details